Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review

OBJECTIVES: First, to investigate if switching biological disease-modifying antirheumatic drugs (bDMARDs) after the failure to prior bDMARD is efficacious in patients with axial spondyloarthritis (axSpA). Second, to evaluate the influence on this efficacy of (1) the reason to discontinue prior tumou...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:RMD Open
Main Authors: Navarro-Compán, Victoria, Plasencia-Rodríguez, Chamaida, de Miguel, Eugenio, Diaz del Campo, Petra, Balsa, Alejandro, Gratacós, Jordi
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2017
Teme:
Spondyloarthritis
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5640114/
https://ncbi.nlm.nih.gov/pubmed/29071119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000524
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki